title: Expanding the screening for diabetes in pregnancy: overmedicalization or the right thing to do?
authors: Dr. Saade is from the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, TX; e-mail: gsaade@utmb.edu.
authors: George R
authors: GR
authors: Saade
mesh_terms: D016640:Diabetes, Gestational / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D011247:Pregnancy
references: National Institutes of Health Consensus Development Conference Panel. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4–6, 2013. Obstet Gynecol 2013;122:358–69.
references: Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al.. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.
references: Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al.. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48.
references: Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.